Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRIMOCHOL vs BRIMOCHOL F vs Carbachol in Presbyopia
NCT04774237Phase 2Completed
- Sponsor
- Tenpoint Therapeutics
- Start
- Mar 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brimonidine in presbyopia, sponsored by Tenpoint Therapeutics. Started Mar 2021; status: completed.
02
Drugs
brimonidine
03
Conditions
presbyopia
Beyond the preview
Go deeper on NCT04774237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04774237.